Certain foods and nutrients were found to influence the risk of developing liver cancer. For example, aflatoxins (toxins from ...

Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking preclinical data for the treatment ...

A new study has established that the follow-up of the fatty liver index (FLI), both baseline and longitudinally, is an ...

Weight loss without diet changes, along with loss of appetite, can be initial warning signs of liver cancer. Your stomach ...

US researchers analyzed national death certificate data to compare trends in hepatocellular carcinoma (HCC)-related mortality and underlying etiologies of chronic liver disease linked to HCC-related ...

A new Lancet study warns liver cancer cases could nearly double by 2050, if no action is taken. The authors emphasise ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for the use of ...

Japanese drugmaker Eisai revealed that its in-house discovered tyrosine kinase inhibitor, Lenvima (lenvatinib mesylate), in combination with the anti-PD-1 antibody, pembrolizumab, and transarterial ...

AstraZeneca has received a positive recommendation from NICE for the use of Imfinzi (durvalumab) with Imjudo (tremelimumab) ...

Primary endpoint is safety; Namodenoson continues to demonstrate a favorable safety profile Ramat Gan, Israel, July 30, 2025 ...

In July 2025, Marengo Therapeutics Inc. organized a phase 1/2 study to assess the safety/tolerability and preliminary ...

While rates of alcohol use disorder have decreased per the report, it’s still the most common substance use disorder. For a ...